Vascular Biogenics Ltd. - stock earnings

VBLT Quarterly earnings

DateEarningsRevenue
2022Q4 -3.3 million USD ? USD
2022Q3 -9.2 million USD 481000 USD
2022Q2 -9.4 million USD 64000 USD
2022Q1 -10.4 million USD 113000 USD
2021Q4 -9.1 million USD 196000 USD
2021Q3 -6.5 million USD 199000 USD
2021Q2 -8.0 million USD 188000 USD
2021Q1 -6.3 million USD 185000 USD
2020Q4 -7.3 million USD 205000 USD
2020Q3 -5.8 million USD 193000 USD

VBLT Yearly earnings

DateEarningsRevenue
2022 -32.3 million USD 658000 USD
2021 -29.9 million USD 768000 USD
2020 -24.2 million USD 922000 USD
2019 -19.4 million USD 562000 USD
2018 -20.5 million USD 585000 USD
2017 -10.1 million USD 13.9 million USD

VBLT

Price: $0.16

52 week price:
0.10
2.20

Dividend Yield: 8.81%

Payout Ratio Range:
-7200.00%
-116.13%

Earnings Per Share: -0.60 USD

P/E Ratio: -2.03

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 272991

Ebitda: -6.4 million

Market Capitalization: 15.0 million

Links: